1-8 of 8
M. Helen Huls
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Enhancing the in vivo expansion of adoptively transferred EBV-specific CTL with lymphodepleting CD45 monoclonal antibodies in NPC patients

Chrystal U. Louis, Karin Straathof, Catherine M. Bollard, Claudia Gerken, M. Helen Huls, M. Victoria Gresik, Meng-Fen Wu, Heidi L. Weiss, Adrian P. Gee, Malcolm K. Brenner, Cliona M. Rooney, Helen E. Heslop, Stephen Gottschalk
Journal: Blood
Blood (2009) 113 (11): 2442–2450.
https://doi.org/10.1182/blood-2008-05-157222
Published: 2009
Includes: Supplemental data
Journal Articles

Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer

Clinical Trials & Observations
Catherine M. Bollard, Stephen Gottschalk, Ann M. Leen, Heidi Weiss, Karin C. Straathof, George Carrum, Mariam Khalil, Meng-fen Wu, M. Helen Huls, Chung-Che Chang, M. Victoria Gresik, Adrian P. Gee, Malcolm K. Brenner, Cliona M. Rooney, Helen E. Heslop
Journal: Blood
Blood (2007) 110 (8): 2838–2845.
https://doi.org/10.1182/blood-2007-05-091280
Published: 2007
Journal Articles

Treatment of nasopharyngeal carcinoma with Epstein-Barr virus–specific T lymphocytes

Clinical Trials & Observations
Karin C. M. Straathof, Catherine M. Bollard, Uday Popat, M. Helen Huls, Teresita Lopez, M. Craig Morriss, Mary V. Gresik, Adrian P. Gee, Heidi V. Russell, Malcolm K. Brenner, Cliona M. Rooney, Helen E. Heslop
Journal: Blood
Blood (2005) 105 (5): 1898–1904.
https://doi.org/10.1182/blood-2004-07-2975
Published: 2005
Journal Articles

Prompt versus preemptive intervention for EBV lymphoproliferative disease

Clinical Trials & Observations Brief Report
Hans-Joachim Wagner, Yee Chung Cheng, M. Helen Huls, Adrian P. Gee, Ingrid Kuehnle, Robert A. Krance, Malcolm K. Brenner, Cliona M. Rooney, Helen E. Heslop
Journal: Blood
Blood (2004) 103 (10): 3979–3981.
https://doi.org/10.1182/blood-2003-12-4287
Published: 2004
Journal Articles

Generating CTLs against the subdominant Epstein-Barr virus LMP1 antigen for the adoptive immunotherapy of EBV-associated malignancies

Stephen Gottschalk, Oliver L. Edwards, Uluhan Sili, M. Helen Huls, Tatiana Goltsova, Alan R. Davis, Helen E. Heslop, Cliona M. Rooney
Journal: Blood
Blood (2003) 101 (5): 1905–1912.
https://doi.org/10.1182/blood-2002-05-1514
Published: 2003
Journal Articles

Autologous Epstein-Barr virus (EBV)–specific cytotoxic T cells for the treatment of persistent active EBV infection

Barbara Savoldo, M. Helen Huls, Zhensheng Liu, Takayuki Okamura, Hans-Dieter Volk, Petra Reinke, Robert Sabat, Nina Babel, James F. Jones, Jennifer Webster-Cyriaque, Adrian P. Gee, Malcolm K. Brenner, Helen E. Heslop, Cliona M. Rooney
Journal: Blood
Blood (2002) 100 (12): 4059–4066.
https://doi.org/10.1182/blood-2002-01-0039
Published: 2002
Journal Articles

Adapting a transforming growth factor β–related tumor protection strategy to enhance antitumor immunity

Catherine M. Bollard, Claudia Rössig, M. Julia Calonge, M. Helen Huls, Hans-Joachim Wagner, Joan Massague, Malcolm K. Brenner, Helen E. Heslop, Cliona M. Rooney
Journal: Blood
Blood (2002) 99 (9): 3179–3187.
https://doi.org/10.1182/blood.V99.9.3179
Published: 2002
Journal Articles

CD20 monoclonal antibody (rituximab) for therapy of Epstein-Barr virus lymphoma after hemopoietic stem-cell transplantation

Brief Report
Ingrid Kuehnle, M. Helen Huls, Zhensheng Liu, Micah Semmelmann, Robert A. Krance, Malcolm K. Brenner, Cliona M. Rooney, Helen E. Heslop
Journal: Blood
Blood (2000) 95 (4): 1502–1505.
https://doi.org/10.1182/blood.V95.4.1502.004k40_1502_1505
Published: 2000